Cleveland, OHNCT06694558Now EnrollingIRB Ready

Chronic Kidney Disease(CKD) Clinical Trial in Cleveland, OH

Access cutting-edge chronic kidney disease(ckd) treatment through this clinical trial at a research site in Cleveland. Study-provided care at no cost to qualified participants.

Sponsored by The Cleveland Clinic

Quick Self-Assessment

See if you qualify for this Cleveland location

Preparing your pre-screening questions…

Expert Care in Cleveland

Access chronic kidney disease(ckd) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related chronic kidney disease(ckd) treatment provided free

Apply for This Cleveland Location

Check if you qualify for this chronic kidney disease(ckd) clinical trial in Cleveland, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cleveland

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cleveland site if eligible
  4. 4Begin participation

About This Chronic Kidney Disease(CKD) Study in Cleveland

This is a cross-sectional study in patients with Type 1 diabetes (TID) and chronic kidney disease (CKD) to test if time in range (TIR) affects the degree of hyperglycemia required for monocyte activation, podocyte injury, and assess if monocyte activation is attenuated by glucagon-like peptide (GLP-1) agonist treatment ex vivo.

Sponsor: The Cleveland Clinic

Who Can Participate

Inclusion Criteria

T1D CKD subjects:
Adults, males or females diagnosed with T1D
Age 18-65 years
Diagnosed with CKD (eGFR 60-90 ml/min/1.73 m2)
Diagnosed with albuminuria (UACR 30-500 mg/g)
On insulin injections or pump
On CGM Based on baseline CGM metrics, the investigators will stratify subjects to 2 groups Group A (Lower TIR group): TIR\<60%, A1c 7.5-9.5 Group B (Higher TIR group): TIR\>70% A1c 5.0-7.0
Controls: T1D subjects without CKD
Adults, males or females diagnosed with T1D
Age 18-65 years
No CKD (eGFR \>90 ml/min/1.73 m2)
No albuminuria (UACR \<30 mg/g)
On insulin injections or pump
On CGM Based on baseline CGM metrics, the investigators will stratify subjects to 2 groups Group A (Lower TIR group): TIR\<60%, A1c 7.5-9.5 Group B (Higher TIR group): TIR\>70% A1c 5.0-7.0

Exclusion Criteria

Hemoglobin \<9
On GLP-1 agonist or DPP4 inhibitor or sodium-glucose co-transporter-2 inhibitors use within 30 days
pregnancy or plans to become pregnant
On steroids
Diagnosed with cancer, immunosuppression/autoimmune conditions
Reported heavy alcohol use or recreational drug use
Any condition which jeopardizes patient safety or affects monocytes at physician's discretion

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cleveland?

Yes, this clinical trial (NCT06694558) has an active research site in Cleveland, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Chronic Kidney Disease(CKD) Treatment Options in Cleveland, OH

If you're searching for chronic kidney disease(ckd) treatment options in Cleveland, OH, this clinical trial (NCT06694558) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cleveland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced chronic kidney disease(ckd) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all chronic kidney disease(ckd) clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Cleveland, OH

See all ankylosing spondylitis clinical trials recruiting in Cleveland — not just this study.

Browse Ankylosing Spondylitis Trials in Cleveland →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsChronic Kidney Disease TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Cleveland?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cleveland, OH